Wuxi Beta and Shanghai Medissi Biotechnology Co., Ltd. to establish a cooperative relationship

Release time:

2016-06-24

On June 24, 2016, Wuxi Beta Pharmaceutical Technology Co., Ltd. and Shanghai Medisi Biotechnology Co., Ltd. signed a framework agreement to complement each other's advantages and do their best to cooperate in the development of C14 labeling of Chinese medicine and animal drug generation research. Actively promote the development of my country's new drug development industry.

On June 24, 2016, Wuxi Beta Pharmaceutical Technology Co., Ltd. and Shanghai Medisi Biotechnology Co., Ltd. signed a framework agreement to complement each other's advantages and do their best to cooperate in the development of C14 labeling of Chinese medicine and animal drug generation research. Actively promote the development of my country's new drug development industry.